Clinical trial
A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Assess Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Chronic Rhinosinusitis
NCT01706484 is registered in ClinicalTrials.gov with Bionorica SE as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Assess Efficacy and Safety of Two Dosages of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Chronic Rhinosinusitis
- Lead sponsor
- Bionorica SE
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- July 31, 2014
- Enrollment
- 927 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic sinusitis